Furthermore, in melanoma patients, the CD8+ T cell responses specific for immunodominant epitopes derived from the self shared tumor antigens MelanA/Mrt1 or NY-ESO1 display also a limited clonal heterogeneity. This evidence concerns the gene CD8A and neoplasm.